Sandra Levy
ARTICLES BY THIS AUTHOR
- 2/18/2021
Keycentrix taps Binny John as VP of software development
Former McKesson executive Binny John, will lead Keycentrix’s technology development in his role as vice president of software development. - 2/18/2021
Camber releases generic Northera
Droxidopa capsules are available from Camber in a dosage strength of 300 mg in a 90-count bottle. - 2/18/2021
Report: Pfizer asking FDA to let its COVID-19 vaccine be stored at higher temps
Pfizer and BioNTech SE have asked the Food and Drug Administration to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially allowing for it to be kept in pharmacy freezers. - 2/17/2021
Dr. Reddy's intros generic Prolixin
The Prolixin brand and generic had a market value of $134 million for the 12 months ended December 2020, according to IQVIA. - 2/17/2021
Almirall launches Klisyri
Almirall's Klisyri represents a significant step forward in the treatment of AK due to its short treatment protocol of a once-daily application for 5 days. - 2/17/2021
NACDS names Ayotte SVP of pharmacy, transformation and advocacy
Michael Ayotte, a former CVS executive, will lead the National Association of Chain Drug Stores’ advancement of state pharmacy scope of practice and operations, as well as opioid abuse prevention in the state regulatory and legislative arenas. - 2/16/2021
NCPA: Local pharmacies need more vaccine supply to serve communities
The National Community Pharmacists Association said more COVID-19 vaccine supply is needed by local pharmacies to accelerate the rate of vaccine administration. - 2/16/2021
Lupin intros generic Noxafil
Posaconazole had a market value of roughly $186 million, according to IQVIA December 2020 data. - 2/16/2021
ANI expands leadership team with 3 executive appointments
ANI's new executive team includes Christopher Mutz as chief commercial officer and head of rare diseases, Ori Gutwerg as senior vice president of generics, and Davinder Singh as general manager of Canadian operations. - 2/16/2021
Dr. Reddy's launches generic Xeloda
The Xeloda brand and generic had a market value of $90 million for the year ended October 2020, according to IQVIA.
